Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $95 |
| Triangulated Fair Value | $81 |
| 12-mo Scenario PWEV | $95 |
| Implied Return | -16% |
| Forward P/E | 15.1x |
| Market Cap | $12B |
| 52-Week Range | $85 – $127 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Defensive Re-Rate' (8% weight) — targets $150, +57% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($95) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Private-Label / Brand Erosion' (20%) — targets $44, -54% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 55% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.51 vs analyst floor +0.05 → delta +0.46 (n=23 mgmt / 28 Q&A; 64th pctile across the S&P book, z +0.4).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.51 | +0.05 | +0.46 |
| 2026Q1 | +0.42 | +0.15 | +0.27 |
| 2025Q4 | +0.19 | +0.03 | +0.16 |
| 2025Q3 | +0.32 | +0.01 | +0.31 |
News (last 365d, 1000 articles): avg ticker sentiment +0.02 (bullish 16% / bearish 11%)
Scenario Analysis
The tree runs from a structural 'Structural — Private-Label / Brand Erosion' downside ($44) to a 'Bull — Defensive Re-Rate' bull case ($150); the probability-weighted blend (PWEV $95) is -1% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 20% | $44 | -54% |
| Consumer / Input Recession | 18% | $78 | -18% |
| Base — Pricing-Led Organic Growth | 34% | $101 | +6% |
| Growth — Premium Innovation + EM | 20% | $127 | +33% |
| Bull — Defensive Re-Rate | 8% | $150 | +57% |
| Probability-Weighted (PWEV) | — | $95 | -1% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Private-Label / Brand Erosion (20%, $44). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 43.85; probability: 0.2.
- Consumer / Input Recession (18%, $78). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising. Drivers — implied_target: 77.91; probability: 0.18.
- Base — Pricing-Led Organic Growth (34%, $101). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns. Drivers — implied_target: 100.81; probability: 0.34.
- Growth — Premium Innovation + EM (20%, $127). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 127.28; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $150). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets. Drivers — implied_target: 149.7; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $84 | -12% |
| Peer P/E re-rate | multiple | $149 | +56% |
| Peer EV/Revenue re-rate | multiple | $188 | +97% |
| Scenario PWEV | multiple | $95 | -1% |
| DCF (5-year + terminal) | cash flow + terminal × | $69 | -27% |
| Triangulated (weighted) | — | $81 | -16% |
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $84 + scenario PWEV $95, ≈ spot); the weighted blend $81 (-16%) sits below it because the cash-flow DCF ($69) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $84 and 40% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (55% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 7.5%, 13x terminal FCF multiple → $69. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 23.58x) implies $149. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Household & Personal Care | $6.8B | 100% | 4% | 14% | 15x | 3% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) |
| net_debt_or_cash_b | -3.3 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.03 |
| div_yield | 0.052 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | private-label / brand erosion |
| upside | premium innovation + emerging markets |
Industry Context — Consumer Staples — Household
This name sits in the Consumer Staples — Household as a household_personal. branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: PG (household_personal) · CL (household_personal) · KVUE (household_personal) · KMB (household_personal) · EL (household_personal) · CHD (household_personal) · CLX (household_personal)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — Private-Label / Brand Erosion | 38% | 38% | |
| Mid-Cycle — Pricing-Led Organic Growth | 34% | 34% | |
| Upside — Premium Innovation / EM | 28% | 28% |
On the cluster's key downside — Structural — Private-Label / Brand Erosion () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_household cycle is the shared macro driver. Driver — branded HPC pricing power + organic volume + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+2 | $7B | $1B | $0B | $0B | $1B | $1B |
| FY+3 | $8B | $1B | $0B | $0B | $1B | $1B |
| FY+4 | $8B | $1B | $0B | $0B | $1B | $1B |
| FY+5 | $8B | $1B | $0B | $0B | $1B | $1B |
| Terminal | — | — | — | — | $1B × 13x | $8B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.5% · Σ PV(FCF) $3B + PV(terminal) $8B = EV $12B; + net cash → equity $8B ÷ diluted shares 0.12B = $69/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $109/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 14% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CL | 3.823x | 23.58x | 4% | 21% |
| KMB | 2.535x | 14.22x | 4% | 20% |
| CHD | 4.022x | 26.04x | 4% | 20% |
| Median | 3.823x | 23.58x | — | — |
Peer-median fwd P/E → $149; EV/Rev → $188.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $69 | 47% | $32 |
| Scenario PWEV | $95 | 33% | $32 |
| Monte Carlo median | $84 | 20% | $17 |
| Triangulated | — | 100% | $81 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 9.1x | 11.0x | 13.0x | 14.9x | 16.9x |
|---|---|---|---|---|---|
| 6% | $55 | $66 | $78 | $89 | $100 |
| 6% | $52 | $62 | $73 | $84 | $95 |
| 8% | $49 | $59 | $69 | $79 | $90 |
| 8% | $46 | $55 | $66 | $75 | $85 |
| 10% | $43 | $52 | $62 | $71 | $81 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $41 | $50 | $59 | $68 | $77 |
| -1.5pp | $45 | $55 | $64 | $73 | $83 |
| +0.0pp | $49 | $59 | $69 | $79 | $89 |
| +1.5pp | $54 | $64 | $75 | $86 | $96 |
| +3.0pp | $58 | $70 | $81 | $92 | $104 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $49 | $89 | $40 |
| Revenue CAGR ±3pp | $59 | $81 | $22 |
| Terminal × ±15% | $59 | $80 | $21 |
| WACC ±1pp | $66 | $73 | $8 |
| FCF conversion ±10% | $69 | $69 | $0 |
Company lever — SoP/share vs Household & Personal Care multiple (AI re-rating) (base 15x)
| Multiple | 10.5x | 12.8x | 15.0x | 17.2x | 19.5x |
|---|---|---|---|---|---|
| SoP/share | $563 | $692 | $816 | $939 | $1,069 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 13×, FY+5 revenue $8B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
A miss on Gross Margin drops the case toward the structural target $44.
Fact / Inference / Speculation
- FACT: Spot $95; 52-week range $85–$127; engine rating HOLD; base-case target $94 (-1%).
- INFERENCE: Triangulated FV $81 (-16%). Gross Margin explains 55% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 55% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $89 (-7% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (55% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).